Sonova AG

Sonova AG is a Swiss hearing-care company founded in 1947, headquartered in Switzerland and active in more than 100 countries. It develops and delivers hearing care solutions - hearing aids, cochlear implants, wireless communication systems and audiological care services - for people with hearing loss. The company employs more than 18,000 people and reports sales of CHF 3.9 billion and a net profit of CHF 547 million for FY 2024/25, holding over 1,800 patents and design rights.

The business is organised around a portfolio of brands. Hearing instruments are developed under Phonak and Unitron; cochlear implant systems come from Advanced Bionics; audiological care services are delivered through a global network including AudioNova; and consumer hearing products include Sennheiser-branded offerings under licence. Wireless communication systems round out the range, supporting hearing and connectivity across product lines.

Sonova operates in hearing healthcare, medical devices, audiology and consumer hearing, addressing a global population of more than 1.5 billion people affected by hearing loss. The company describes its mission as enabling people with hearing loss to live without limitations, and pairs that social objective with a stated commitment to business performance and research and development.